Sage Therapeutics, Inc. is a clinical-stage biopharmaceutical company committed to discovering, developing, and commercializing novel medicines to transform the lives of patients with life-altering central nervous system (CNS) disorders. We are thinking differently about drug discovery, and our goal is to develop products that may address gaps in available treatment options.